Prophylactic Antibiotic Post Knee Surgery
For knee surgery, administer cefazolin 2g IV within 30-60 minutes before skin incision as a single dose, with re-dosing of 1g if surgery exceeds 4 hours; limit prophylaxis to the operative period with a maximum of 24 hours. 1
Antibiotic Selection and Dosing
The first-generation cephalosporin cefazolin is the preferred agent for knee surgery prophylaxis based on multiple international guidelines 1. The standard regimen is:
- Primary dose: Cefazolin 2g IV slow infusion
- Timing: 30-60 minutes before skin incision 2, 3
- Intraoperative re-dosing: 1g if surgery duration exceeds 4 hours 1
- Maximum duration: Limited to operative period, 24 hours maximum 1
Alternative cephalosporins include cefamandole or cefuroxime 1.5g IV, with re-dosing of 0.75g if duration exceeds 2 hours 1.
Allergy Considerations
For patients with beta-lactam allergy:
Vancomycin is also indicated for suspected/proven MRSA colonization, reoperation in units with MRSA ecology, or previous antibiotic therapy 1. The infusion must end at the latest at incision start, ideally 30 minutes before 1.
Critical Timing Evidence
Timing is crucial for efficacy. Administering cephalosporin within 60 minutes before incision significantly reduces both any SSI (aOR 0.56,95% CI 0.36-0.89) and deep SSI (aOR 0.29,95% CI 0.15-0.59) compared to administration at or after incision 3. Even administration 60+ minutes before incision was superior to at/after incision for deep SSI prevention (aOR 0.27,95% CI 0.09-0.83) 3.
Duration: Single Dose vs Extended
A single preoperative dose is superior to extended prophylaxis. A 2024 meta-analysis of 295,654 patients demonstrated that single-dose prophylaxis reduced periprosthetic joint infection compared to extended regimens (OR 0.78,95% CI 0.63-0.98) 4. There is no evidence supporting postoperative antibiotic prophylaxis beyond the operative period 2, and extending prophylaxis beyond 24 hours provides no additional benefit 3.
Special Considerations for Knee Surgery
Joint Prosthesis/Arthroplasty
For total knee arthroplasty with implant placement, the same cefazolin 2g regimen applies 1. Recent pharmacokinetic data shows cefazolin achieves adequate tissue concentrations and may retain activity against methicillin-resistant CoNS despite categorical non-susceptibility 5.
Arthroscopy Without Implant
No antibiotic prophylaxis is required for arthroscopy without implant placement, including meniscectomy 1.
Open Fractures (Trauma Setting)
For major extremity trauma with open fractures:
- Type I-II open fractures: Cefazolin 2g IV 6
- Type III open fractures: Cefazolin PLUS additional gram-negative coverage (strong recommendation) 6
- Early antibiotic delivery is critical to lower deep infection risk 6
Aminoglycoside Addition: Not Routinely Recommended
Do not routinely add gentamicin or tobramycin to cefazolin for standard knee arthroplasty. A 2025 study of 152,493 patients found no difference in SSI rates, prosthetic joint infection, or 5-year revision rates between cefazolin alone versus cefazolin plus aminoglycoside 7. While aminoglycosides improve gram-negative coverage in pharmacokinetic studies 5, this does not translate to clinical benefit in routine practice 7.
Weight-Based Dosing
Standard 2g cefazolin dosing is appropriate for patients <120kg. For patients ≥120kg, consider higher doses (3g), though evidence shows correct weight-adjusted dosing reduces SSI risk (aOR 0.68,95% CI 0.47-0.99) 3, 8.
Common Pitfalls to Avoid
- Administering antibiotics at or after incision rather than 30-60 minutes before—this dramatically increases infection risk 3
- Extending prophylaxis beyond 24 hours—provides no benefit and increases resistance 2, 4, 3
- Changing antibiotic dose intraoperatively without indication—associated with increased SSI risk (aOR 1.76) 3
- Using non-cephalosporin antibiotics without clear indication—associated with higher SSI rates 3
- Forgetting intraoperative re-dosing for prolonged procedures >4 hours 1
Target Pathogens
Cefazolin provides coverage against the primary organisms responsible for knee surgery infections: Staphylococcus aureus, coagulase-negative staphylococci (S. epidermidis), and select gram-negative organisms (E. coli, Proteus, Klebsiella) 9, 1.